Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years
暂无分享,去创建一个
Janice Fletcher | Pamela Joy | Kevin Carpenter | David Cowley | Veronica Wiley | Bridget Wilcken | J. Fletcher | J. Christodoulou | B. Lewis | C. Ellaway | A. Boneh | J. Yaplito-Lee | J. Pitt | D. Cowley | P. Joy | M. Haas | B. Wilcken | V. Wiley | K. Carpenter | E. Ranieri | E. Kirk | Heidi Peters | John Christodoulou | H. Peters | J. Mcgill | Joy Yaplito-Lee | Edwin P Kirk | Avihu Boneh | Marion Haas | Carolyn Ellaway | Barry Lewis | Enzo Ranieri | Francis Bowling | Jim McGill | James Pitt | F. Bowling
[1] N. Holtzman. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. , 2004, The Journal of pediatrics.
[2] J. Christodoulou,et al. Glutaric aciduria type I: outcome following detection by newborn screening , 2008, Journal of Inherited Metabolic Disease.
[3] K. Bhattacharya,et al. Newborn screening may fail to identify intermediate forms of maple syrup urine disease , 2006, Journal of Inherited Metabolic Disease.
[4] S. Edland,et al. A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. , 2004, American journal of human genetics.
[5] K. Gibson,et al. Mutations in the AUH gene cause 3‐methylglutaconic aciduria type I , 2003, Human mutation.
[6] R. Norman,et al. International perspectives on the cost-effectiveness of tandem mass spectrometry for rare metabolic conditions. , 2009, Health policy.
[7] P. Rinaldo,et al. Making the case for objective performance metrics in newborn screening by tandem mass spectrometry. , 2006, Mental retardation and developmental disabilities research reviews.
[8] R. Pollitt. International perspectives on newborn screening , 2006, Journal of Inherited Metabolic Disease.
[9] J. Fletcher,et al. Newborn screening for 3‐methylcrotonyl‐CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment , 2006, Human mutation.
[10] Michael S. Watson,et al. Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary , 2006, Pediatrics.
[11] Martin Lindner,et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. , 2003, Pediatrics.
[12] J. Vockley,et al. Short-chain acyl-coenzyme A dehydrogenase deficiency. , 2008, Molecular genetics and metabolism.
[13] American College of Medical Genetics Newborn Screening Expert Group. Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary. PEDIATRICS 2006;117:S296–S307. , 2006, Pediatrics.
[14] A. Boneh,et al. Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. , 2008, Molecular genetics and metabolism.
[15] B. Wilcken,et al. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[16] I. Knerr,et al. Reduced incidence of severe metabolic crisis or death in children with medium chain acyl-CoA dehydrogenase deficiency homozygous for c.985A>G identified by neonatal screening. , 2005, Molecular genetics and metabolism.
[17] D. Millington,et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005 , 2006, Journal of Inherited Metabolic Disease.
[18] E. Puffenberger,et al. Type I glutaric aciduria, part 1: Natural history of 77 patients , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.
[19] J. Häberle,et al. Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1). , 2003, Molecular genetics and metabolism.
[20] B. Wilcken,et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. , 2003, The New England journal of medicine.
[21] J. Svedmyr,et al. Systemic effects of a short course of betamethasone compared with high‐dose inhaled budesonide in early childhood asthma , 1999, Acta paediatrica.
[22] J. Zschocke,et al. Decline of Acute Encephalopathic Crises in Children with Glutaryl-CoA Dehydrogenase Deficiency Identified by Newborn Screening in Germany , 2007, Pediatric Research.
[23] R. Fingerhut,et al. Maple syrup urine disease: Favourable effect of early diagnosis by newborn screening on the neonatal course of the disease , 2006, Journal of Inherited Metabolic Disease.
[24] J. Fletcher,et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study , 2007, The Lancet.
[25] R. Norman,et al. Economic Evaluation of Tandem Mass Spectrometry Newborn Screening in Australia , 2009, Pediatrics.
[26] A F Roche,et al. CDC growth charts: United States. , 2000, Advance data.